Tech Company Financing Transactions
Coave Therapeutics Funding Round
Coave Therapeutics secured a $33 million Series A investment round on 1/9/2025. Investors included Bpifrance, Novo Holdings and Fund+.
Transaction Overview
Company Name
Announced On
1/9/2025
Transaction Type
Venture Equity
Amount
$33,000,000
Round
Series A
Investors
Bpifrance (Lead Investor)
Novo Holdings (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its proprietary ALIGATER� platform to enhance targeting, specificity, efficacy and manufacturability of genetic medicines with broad clinical applications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Paris, Undisclosed
France
Paris, Undisclosed
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Coave Therapeutics, a Paris, France-based genetic medicines company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rodolphe Clerval
Browse more venture capital transactions:
Prev: 1/9/2025: Dataships venture capital transaction
Next: 1/9/2025: Leyden Labs venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs